Skin-marking compositions and devices, and their use

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 9, 436 86, 436 90, 436172, 514453, A61K 4900, G01N 3100, G01N 3122

Patent

active

045728313

ABSTRACT:
Fluorescamine or like compounds react with the epidermis when applied to the skin and form, within about 15 to 30 minutes after application to the skin, a long-lasting reaction product, which is invisible in ordinary light but which fluoresces intensely under ultraviolet light. Such markings resist removal by abrasion and repeated washings. Organic solutions of such compounds, perferably containing a fugitive dyestuff or pigment and used as the marking fluid of a conventional felt-tipped pen, can be used to mark skin for radiological or diagnostic purposes. Inanimate objects can be coated with these compounds to detect human contact therewith.

REFERENCES:
patent: 3640889 (1972-02-01), Stewart
patent: 3812181 (1974-03-01), Leimgruber et al.
patent: 3830629 (1974-08-01), Leimgruber et al.
patent: 3871825 (1974-03-01), Leimgruber et al.
patent: 3969373 (1976-07-01), Cleeland et al.
patent: 4045487 (1977-08-01), Cleeland et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Skin-marking compositions and devices, and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Skin-marking compositions and devices, and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Skin-marking compositions and devices, and their use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1012640

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.